Corporate Social Responsibility

Biometric technology faces litigation.

Italy's largest bank bucks the trend towards greater social media presence.

Maria Gotsch, president and CEO of the Partnership Fund for New York City, visited Global Finance to discuss the Fund and how its FinTech Innovation Lab is designed to promote innovations that yield useful benefits.

Automation meets finance.

Big companies are leading the charge into green energy as the long-term cost benefits become more apparent, yet political hurdles remain.

One of the three global ratings agencies adds ESG to its criteria for rating creditworthiness.

Sustainable finance is here to stay. Now, CFOs must learn to navigate an often-bewildering thicket of new standards and benchmarks.

The gap in both income and wealth continues to grow, sparking political backlash around the globe. Is it also becoming a drag on growth?

This year's World Economic Forum in Davos is happening in an era of rising protectionism and de-globalization.

Women are getting into more board seats and C-suites, yet progress is still hard-won and parity a long way off.

Scientists offer dire warning on climate change.

Rising interest rates show no sign of dampening dividend payouts or stock buybacks. Not yet, at least.

Companies worldwide struggle to measure and report how well they are “doing good” as they do well for their stakeholders.

Changes in technology, regulation and the distribution of wealth are reshaping private banking throughout the Americas.

Tensie Whelan, director of the Center for Sustainable Business at New York University’s Stern School of Business, talks about the growing bottom-line case for sustainable practices. 

Private-sector entities are getting involved in providing aid, education and even jobs to refugees in order to mitigate the crisis. 

The cost of producing solar power has fallen sharply in the past five years—so much that in some cases it can be half the price, or even less, of conventional power. Experts predict solar's cost will continue to plummet. 

US: Heather Bresch, the CEO of Mylan, an American pharmaceuticals company, finds herself at the center of one of the biggest pharma controversies in recent years: price-gouging.

In potentially the biggest foreign corporate takeover ever by a German company, Bayer seeks to buy Monsanto for 62 billion. Werner Bauman gets into agribusiness.

Aung San Suu Kyi, Myanmar’s de facto leader and a Nobel Peace Prize winner, has a change of heart regarding US sanctions against her country.